A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Head and Neck Cancer
Related studies linked through entity extraction aliases.
Hospital Acquired Pneumonia in Temporary Tracheostomy
- Status
- UNKNOWN
- Phase
- N/A
Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)
- Status
- RECRUITING
- Phase
- N/A
SOTO: Treatment Sensitivity of Organoids to Predict Treatment Outcome
- Status
- RECRUITING
- Phase
- N/A
Investigation of Effects of Physiotherapy Interventions on Mechanical Properties of Muscle in Head and Neck Cancer
- Status
- COMPLETED
- Phase
- NA
FT536 Monotherapy and in Combination With Monoclonal Antibodies in Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
InGReS: Intra-treatment Image Guided Adaptive Radiotherapy Dose-escalation Study
- Status
- UNKNOWN
- Phase
- NA
Trial Comparing Different Follow-up Strategies
- Status
- TERMINATED
- Phase
- NA
Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN, High Risk, Cisplatin-ineligible Participants (XRAY VISION)
- Status
- TERMINATED
- Phase
- PHASE3
Individualized Follow-Up for Head and Neck Cancer
- Status
- RECRUITING
- Phase
- N/A
Immune Biomarker Study for Head and Neck Cancer
- Status
- RECRUITING
- Phase
- N/A
PATH Trial: Personalized Approaches in the Treatment of Head and Neck Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- NA
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Status
- RECRUITING
- Phase
- N/A
Clinical Study On Acute Radiotherapy-Induced Oral Mucositis In Patients With Locally Advanced Head And Neck Tumors
- Status
- COMPLETED
- Phase
- PHASE3
ATATcH Alternating Treatment Plans for Advanced Cancer
- Status
- RECRUITING
- Phase
- PHASE2
FMISO-based Adaptive Radiotherapy for Head and Neck Cancer
- Status
- RECRUITING
- Phase
- NA
Identification of Predictive Factors for the Response to Anti-Programmed Cell Death Protein 1 (PD1) Immunotherapy in Head and Neck Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- N/A
Non-randomized, Open-label Study of Intralesional Nivolumab for High Risk Oral Premalignant Lesions
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Clinical Registry of Long-Term Dental Outcomes in Head and Neck Cancer Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Pilot Study of Glutamine PET Imaging of Head and Neck Squamous Cell Carcinoma
- Status
- TERMINATED
- Phase
- EARLY_PHASE1